Dimed S.A. Distribuidora de Medicamentos (PNVL3) — Working Capital to Net Assets Ratio
Dimed S.A. Distribuidora de Medicamentos (PNVL3) has a Working Capital to Net Assets ratio of 76.2% as of December 2025. Working capital of R$976.92 Million (current assets of R$2.30 Billion minus current liabilities of R$1.32 Billion) is measured against net assets of R$1.28 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Dimed S.A. Distribuidora de Medicamentos to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Dimed S.A. Distribuidora de Medicamentos Working Capital to Net Assets (2004–2025)
This chart shows how Dimed S.A. Distribuidora de Medicamentos's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the ratio stands at 76.2%, reflecting working capital of R$976.92 Million against net assets of R$1.28 Billion BRL. Check PNVL3 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Dimed S.A. Distribuidora de Medicamentos (2004–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Dimed S.A. Distribuidora de Medicamentos from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PNVL3 market cap.
| Year | WC/NA Ratio | Working Capital (BRL) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 76.2% | R$976.92 Million | R$1.28 Billion | R$2.30 Billion | R$1.32 Billion | ▲ +9.2 pp |
| 2024 | 67.1% | R$827.92 Million | R$1.23 Billion | R$2.01 Billion | R$1.18 Billion | ▲ +6.9 pp |
| 2023 | 60.1% | R$705.65 Million | R$1.17 Billion | R$1.84 Billion | R$1.13 Billion | ▲ +10.5 pp |
| 2022 | 49.7% | R$550.31 Million | R$1.11 Billion | R$1.56 Billion | R$1.01 Billion | ▼ -5.8 pp |
| 2021 | 55.4% | R$580.11 Million | R$1.05 Billion | R$1.40 Billion | R$814.97 Million | ▼ -13.7 pp |
| 2020 | 69.1% | R$698.78 Million | R$1.01 Billion | R$1.38 Billion | R$677.72 Million | ▲ +2.4 pp |
| 2019 | 66.8% | R$349.89 Million | R$524.18 Million | R$851.14 Million | R$501.24 Million | ▲ +11.4 pp |
| 2018 | 55.4% | R$256.90 Million | R$463.91 Million | R$727.13 Million | R$470.23 Million | ▼ -15.2 pp |
| 2017 | 70.6% | R$301.26 Million | R$426.75 Million | R$705.02 Million | R$403.77 Million | ▲ +13.0 pp |
| 2016 | 57.6% | R$219.96 Million | R$381.65 Million | R$590.44 Million | R$370.48 Million | ▼ -7.5 pp |
| 2015 | 65.2% | R$224.28 Million | R$344.14 Million | R$539.88 Million | R$315.61 Million | ▼ -5.4 pp |
| 2014 | 70.6% | R$219.78 Million | R$311.30 Million | R$508.35 Million | R$288.56 Million | ▲ +9.1 pp |
| 2013 | 61.5% | R$170.22 Million | R$276.90 Million | R$421.17 Million | R$250.95 Million | ▼ -12.4 pp |
| 2012 | 73.8% | R$172.49 Million | R$233.64 Million | R$401.20 Million | R$228.72 Million | ▼ -0.1 pp |
| 2011 | 73.9% | R$147.30 Million | R$199.24 Million | R$361.47 Million | R$214.17 Million | ▼ -4.4 pp |
| 2010 | 78.3% | R$135.46 Million | R$173.03 Million | R$314.47 Million | R$179.01 Million | ▼ -3.8 pp |
| 2009 | 82.1% | R$124.69 Million | R$151.86 Million | R$282.22 Million | R$157.54 Million | ▲ +0.2 pp |
| 2008 | 81.9% | R$107.09 Million | R$130.81 Million | R$232.79 Million | R$125.70 Million | ▼ -0.9 pp |
| 2007 | 82.8% | R$103.79 Million | R$125.39 Million | R$221.79 Million | R$118.00 Million | ▼ -3.0 pp |
| 2006 | 85.8% | R$101.00 Million | R$117.74 Million | R$206.65 Million | R$105.66 Million | ▲ +1.3 pp |
| 2005 | 84.4% | R$91.35 Million | R$108.19 Million | R$190.24 Million | R$98.89 Million | ▲ +5.5 pp |
| 2004 | 78.9% | R$79.05 Million | R$100.20 Million | R$157.18 Million | R$78.13 Million | — |